Unknown PHASE4 INTERVENTIONAL NCT00199121

A Pilot Study of Triple NtRTI/NsRTI Therapy in Antiretroviral Naive HIV-1 Infected Patients

An Open, Single-Arm, Multi-Center, Phase IV Pilot Study of Treatment of Antiretroviral Naive HIV-1 Infected Patients With Tenofovir Disoproxil Fumarate in Combination With Emtricitabine and Zidovudine

Sponsor: Gilead Sciences

Conditions HIV

Interventions Zidovudine (drug)

Updated 6 times since 2017 Last updated: Dec 13, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00199121, this PHASE4 trial focuses on HIV and remains ongoing. Sponsored by Gilead Sciences, it has been updated 6 times since 2026, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE4
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Gilead Sciences
Johann Wolfgang Goethe University Hospital

Data source: Johann Wolfgang Goethe University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Frankfurt am Main, Germany